Related Experiment Video
Updated: Jan 12, 2026

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
Isolation and characterization of a novel lytic bacteriophage vB_EcoS_P78 against multidrug-resistant Escherichia
Rong Wen1, Jiahao Tong1, Shoude Liu1
1National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, Hubei, China; National Engineering Research Center of Microbial Pesticides, Huazhong Agricultural University, Wuhan 430070, China; College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, China; Hubei Hongshan Laboratory, Wuhan 430070, China.
Abstract:
Escherichia coli phage vB_EcoS_P78, a novel bacteriophage isolated from swine feces, exhibits typical siphovirus morphology with an isometric head and a non-contractile tail, forming clear plaques approximately 4 mm in diameter. It demonstrated a broad host range, lysing 75 % of tested ESBL-producing and MDR E. coli clinical isolates across multiple serogroups. The phage displayed strong stability, retaining activity at temperatures up to 50 °C and within a pH range of 3-10. Results from one-step growth assays showed a 20-minute latent period and that each infected cell produced a burst size of 220 PFU. Whole-genome sequencing revealed a 44,574 bp dsDNA genome containing 58 ORFs, with no antibiotic resistance, and virulence genes detected. Phylogenetic analysis based on intergenomic similarity and core protein phylogeny consistently supported its classification within the genus Dhillonvirus, showing 92.8 % similarity to Escherichia phage JL1. These results indicate that vB_EcoS_P78 represents a novel species of Dhillonvirus with potential therapeutic applications against multidrug-resistant E. coli.
Insights
A novel bacteriophage, Escherichia coli phage vB_EcoS_P78, effectively lyses multidrug-resistant E. coli strains. This siphovirus shows broad host range and stability, indicating potential for phage therapy against resistant bacterial infections.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- Multidrug-resistant (MDR) Escherichia coli poses a significant global health threat.
- Bacteriophages offer a promising alternative or adjunct to conventional antibiotics.
Purpose of the Study:
- To characterize a novel bacteriophage, vB_EcoS_P78, isolated from swine feces.
- To evaluate its lytic activity against MDR E. coli clinical isolates.
- To determine its genomic and phylogenetic characteristics.
Main Methods:
- Isolation and characterization of bacteriophage vB_EcoS_P78.
- Host range determination against ESBL-producing and MDR E. coli.
- Stability assays (temperature, pH).
- One-step growth curve analysis.
- Whole-genome sequencing and phylogenetic analysis.
Main Results:
- Phage vB_EcoS_P78 (siphovirus morphology) lysed 75% of tested MDR E. coli.
- Demonstrated stability at temperatures up to 50°C and pH 3-10.
- Exhibited a 20-minute latent period and burst size of 220 PFU.
- Genome sequenced (44,574 bp dsDNA, 58 ORFs), lacking resistance/virulence genes.
- Phylogenetic analysis placed it as a novel Dhillonvirus species.
Conclusions:
- Phage vB_EcoS_P78 is a novel species within the Dhillonvirus genus.
- Its broad host range, stability, and lytic efficacy suggest significant therapeutic potential against MDR E. coli infections.
Related Concept Videos
Viral Replication: Lytic Cycle
Lytic Cycle of Bacteriophages
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages

